Moreover, the survival of BRCA1- or ATM-deficient cancer patients could be triaged by SETD1A expression, which was not the case for those with deficiencies in BRCA2, nor those with functional copies/levels of these genes (Fig. S6). This evidence concerns the gene SETD1A and cancer.